These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1384823)

  • 21. A unique amino acid substitution, T126I, in human genotype C of hepatitis B virus S gene and its possible influence on antigenic structural change.
    Ren F; Tsubota A; Hirokawa T; Kumada H; Yang Z; Tanaka H
    Gene; 2006 Nov; 383():43-51. PubMed ID: 16963200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein.
    Gripon P; Cannie I; Urban S
    J Virol; 2005 Feb; 79(3):1613-22. PubMed ID: 15650187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutralization determinants of laboratory strains and field isolates of equine arteritis virus: identification of four neutralization sites in the amino-terminal ectodomain of the G(L) envelope glycoprotein.
    Balasuriya UB; Patton JF; Rossitto PV; Timoney PJ; McCollum WH; MacLachlan NJ
    Virology; 1997 May; 232(1):114-28. PubMed ID: 9185595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the antigenic loop of the hepatitis B virus envelope proteins in infectivity of hepatitis delta virus.
    Jaoudé GA; Sureau C
    J Virol; 2005 Aug; 79(16):10460-6. PubMed ID: 16051838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3.
    Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1988 Oct; 141(7):2519-25. PubMed ID: 2459215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune response to hepatitis B virus surface antigen peptides during HBV infection.
    Mishra A; Durgapal H; Manivel V; Acharya SK; Rao KV; Panda SK
    Clin Exp Immunol; 1992 Nov; 90(2):194-8. PubMed ID: 1424274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-additive effects of multiple amino acid substitutions on antigen-antibody recognition.
    Mateu MG; Andreu D; Carreño C; Roig X; Cairó JJ; Camarero JA; Giralt E; Domingo E
    Eur J Immunol; 1992 Jun; 22(6):1385-9. PubMed ID: 1376255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing.
    Neurath AR; Kent SB; Parker K; Prince AM; Strick N; Brotman B; Sproul P
    Vaccine; 1986 Mar; 4(1):35-7. PubMed ID: 2421497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rational design of synthetic peptides to generate antibodies that recognize in situ CD11c(+) putative dendritic cells in horse lymph nodes.
    Espino-Solis GP; Calderon-Amador J; Calderon-Aranda ES; Licea AF; Donis-Maturano L; Flores-Romo L; Possani LD
    Vet Immunol Immunopathol; 2009 Dec; 132(2-4):181-90. PubMed ID: 19682754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delineation of contiguous determinants essential for biological functions of the pre-S sequence of the hepatitis B virus envelope protein: its antigenicity, immunogenicity and cell-receptor recognition.
    Neurath AR; Kent SB; Strick N; Parker K
    Ann Inst Pasteur Virol; 1988; 139(1):13-38. PubMed ID: 2462893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic restriction of immune responsiveness to synthetic peptides corresponding to sequences in the pre-S region of the hepatitis B virus (HBV) envelope gene.
    Neurath AR; Kent SB; Strick N; Stark D; Sproul P
    J Med Virol; 1985 Oct; 17(2):119-25. PubMed ID: 4056755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological cross-reactivity between preS2 sequences of the hepatitis B virus envelope proteins corresponding to serological subtypes adw2 and ayw.
    Neurath AR; Kent SB; Adamowicz P; Riottot MM; Price P; Strick N; Parker K; Petit MA; Budkowska A; Girard M
    Mol Immunol; 1987 Jun; 24(6):561-8. PubMed ID: 3657796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of monoclonal antibodies specific for the pre-S2 region of the hepatitis B virus envelope protein.
    Neurath AR; Adamowicz P; Kent SB; Riottot MM; Strick N; Parker K; Offensperger W; Petit MA; Wahl S; Budkowska A
    Mol Immunol; 1986 Sep; 23(9):991-7. PubMed ID: 2431299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus contains pre-S gene-encoded domains.
    Neurath AR; Kent SB; Strick N; Taylor P; Stevens CE
    Nature; 1985 May 9-15; 315(6015):154-6. PubMed ID: 2581144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological characteristics of a recombinant hepatitis B virus-derived multiple-epitope polypeptide: a study in polyvalent vaccine design.
    Kumar A; Kumar V; Shukla GC; Rao KV
    Vaccine; 1994; 12(3):259-66. PubMed ID: 7513115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the effects of amino acid substitutions and beta-N- vs. alpha-O-glycosylation on the T-cell stimulatory activity and conformation of an epitope on the rabies virus glycoprotein.
    Otvos L; Krivulka GR; Urge L; Szendrei GI; Nagy L; Xiang ZQ; Ertl HC
    Biochim Biophys Acta; 1995 May; 1267(1):55-64. PubMed ID: 7540044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of a putative fusion peptide in the S protein of hepatitis B virus.
    Rodríguez-Crespo I; Gómez-Gutiérrez J; Nieto M; Peterson DL; Gavilanes F
    J Gen Virol; 1994 Mar; 75 ( Pt 3)():637-9. PubMed ID: 8126460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal structure of a dominant B-cell epitope from the preS2 region of hepatitis B virus in the form of an inserted peptide segment in maltodextrin-binding protein.
    Saul FA; Vulliez-le Normand B; Lema F; Bentley GA
    J Mol Biol; 1998 Jul; 280(2):185-92. PubMed ID: 9654443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutational profiling of the variability of individual amino acid positions in the hepatitis B virus matrix domain.
    Schittl B; Bruss V
    Virology; 2014 Jun; 458-459():183-9. PubMed ID: 24928050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cells transfected with human interleukin 6 cDNA acquire binding sites for the hepatitis B virus envelope protein.
    Neurath AR; Strick N; Li YY
    J Exp Med; 1992 Dec; 176(6):1561-9. PubMed ID: 1334115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.